Jump to content
  • Sign Up
0
Scott Adams

Cambridge start-up focuses on celiac disease - Boston Globe

Rate this topic

Recommended Posts

Cambridge start-up focuses on celiac disease

Boston Globe

ImmusanT Inc., a privately-held biotechnology company, said it has established its operations in Cambridge as it looks to develop an immunotherapeutic vaccine and a companion diagnostic and monitoring tool for celiac disease. The company, which said in ...

Start-Up ImmusanT Seeks to Restore Tolerance to Gluten in Celiac Disease with ... PR Newswire (press release)

Confront celiac disease Florida Today

Clues to Gluten Sensitivity Wall Street Journal (blog)

all 10 news articles »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×